Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Hanlin Zhang for being awarded the first Oxford-Elysium Fellowship in cellular health.

This three year fellowship is aimed at supporting the brightest and most promising scientists in their early research careers at the University of Oxford.

The award will support his study into autophagy; the intracellular degradation system which recycles damaged cellular components. Decreased autophagy levels have been associated with age-related diseases such as neurodegeneration and cancer. Hanlin aims to elucidate a novel autophagy signaling pathway and identify novel drug targets within this pathway to increase autophagy levels to achieve healthier ageing.

Commenting on his award, Hanlin said "Human ageing is a very complex process and associated with many severe diseases. Autophagy plays a critical role in regulating cell homeostasis and senescence. I am happy and grateful to be awarded this early-career fellowship. It will help me gain a deeper insight into this novel autophagy and ageing pathway, which might help unveil the ageing mystery.”

Hanlin will be based primarily within the Kennedy Institue under the supervision of Prof. Katja Simon.

 

Funding Body

Image result for elysium health

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.